Journal of Jilin University(Medicine Edition) ›› 2025, Vol. 51 ›› Issue (6): 1670-1678.doi: 10.13481/j.1671-587X.20250623
• Research in clinical medicine • Previous Articles Next Articles
Qiankun CHANG1,Wenying WU1(
),Chunqiang BAI1,Zhichao DING2,Weifang WANG3,Minghan LIU4
Received:2024-11-22
Accepted:2025-02-22
Online:2025-11-28
Published:2025-12-15
Contact:
Wenying WU
E-mail:15633142806@163.com
CLC Number:
Qiankun CHANG,Wenying WU,Chunqiang BAI,Zhichao DING,Weifang WANG,Minghan LIU. Predictive value of breast cancer related parameters combined with positive axillary lymphnode ultrasound features for lymphnode metastasis burden[J].Journal of Jilin University(Medicine Edition), 2025, 51(6): 1670-1678.
Tab.1
Relationships between ultrasound characteristics and axillary lymphnode burden in breast cancer positive axillary lymphnode[n (η/%)]"
| Variable | n | LNB (n=283) | HNB (n=291) | χ2 | P |
|---|---|---|---|---|---|
| Affected side | |||||
| Left | 305 | 151(49.5) | 154(50.5) | 0.011 | 0.917 |
| Right | 269 | 132(49.1) | 137(50.9) | ||
| Quadrant | |||||
| Upper outer | 339 | 149(43.9) | 190(56.1) | 10.580 | 0.014 |
| Outer lower | 106 | 59(55.6) | 47(44.4) | ||
| Upper inner | 97 | 54(55.6) | 43(44.4) | ||
| Inner lower | 32 | 21(65.6) | 11(34.4) | ||
| Distance from the surface (mm) | |||||
| <5 | 271 | 141(52.0) | 130(48.0) | 10.651 | 0.005 |
| 5-10 | 268 | 134(50.0) | 134(50.0) | ||
| >10 | 35 | 8(22.8) | 27(77.2) | ||
| Maximum diameter (mm) | |||||
| ≤2 | 191 | 105(54.9) | 86(45.1) | 3.683 | 0.055 |
| 2-5 | 383 | 178(46.4) | 205(53.6) | ||
| Internal echo | |||||
| Uniform | 283 | 151(53.3) | 132(46.7) | 3.670 | 0.055 |
| Nonuniform | 291 | 132(45.3) | 159(54.7) | ||
| Morphology | |||||
| Regular | 68 | 34(50.0) | 34(50.0) | 0.015 | 0.903 |
| Irregular | 506 | 249(49.2) | 257(50.8) | ||
| Boundary | |||||
| Clear | 247 | 132(53.4) | 115(46.6) | 2.970 | 0.085 |
| Unclear | 327 | 151(46.2) | 176(53.8) | ||
| Calcification | |||||
| Yes | 375 | 189(50.4) | 186(49.6) | 0.521 | 0.471 |
| No | 199 | 94(47.2) | 105(52.8) | ||
| Posterior echo | |||||
| Unchanged | 311 | 156(50.2) | 155(49.8) | 2.349 | 0.309 |
| Enhance | 37 | 22(59.4) | 15(40.6) | ||
| Decay | 226 | 105(46.4) | 121(53.6) | ||
| Blood supply | |||||
| Poor | 238 | 119(50.0) | 119(50.0) | 0.079 | 0.779 |
| Rich | 336 | 164(48.8) | 172(51.2) | ||
| Lymphnode longitudinal diameter (mm) | |||||
| <20 | 370 | 207(55.9) | 163(44.1) | 18.379 | <0.01 |
| ≥20 | 204 | 76(37.2) | 128(62.8) | ||
| Short diameter of lymphnode (mm) | |||||
| <8.6 | 264 | 161(60.9) | 103(39.1) | 26.688 | <0.01 |
| ≥8.6 | 310 | 122(39.3) | 188(60.7) | ||
| Lymphnode aspect ratio | |||||
| <2 | 247 | 138(55.8) | 109(44.2) | 7.481 | 0.006 |
| ≥2 | 327 | 145(44.3) | 182(55.7) | ||
| Suspicious transfer quantity | |||||
| <3 | 67 | 42(62.6) | 25(37.4) | 5.436 | 0.020 |
| ≥3 | 507 | 241(47.5) | 266(52.5) | ||
| Blood supply within lymphnode | |||||
| Poor | 293 | 152(51.8) | 141(48.2) | 1.586 | 0.208 |
| Rich | 281 | 131(46.6) | 150(53.4) | ||
| Lymph node portal | |||||
| Clear | 287 | 170(59.2) | 117(40.8) | 25.868 | <0.01 |
| Unclear | 97 | 31(31.9) | 66(68.1) | ||
| Disappear | 190 | 82(43.1) | 108(56.9) |
Tab.2
Relationships between clinicopathological parameters and axillary lymphnode metastasis burden of breast cancer [n(η/%)]"
| Variable | n | LNB (n=283) | HNB (n=291) | χ2 | P |
|---|---|---|---|---|---|
| Age (year) | |||||
| ≤55 | 355 | 183(51.5) | 172(48.5) | 1.878 | 0.171 |
| >55 | 219 | 100(45.6) | 119(54.4) | ||
| Menstruation | |||||
| Menopause | 259 | 120(46.3) | 139(53.7) | 1.667 | 0.197 |
| Normal | 315 | 163(51.7) | 152(48.3) | ||
| Pathological type | |||||
| Invasive ductal carcinoma | 532 | 265(49.8) | 267(50.2) | 4.875 | 0.181 |
| Invasive lobular carcinoma | 19 | 5(26.3) | 14(73.7) | ||
| Special type cancer | 20 | 11(55.0) | 9(45.0) | ||
| Ductal carcinoma in situ | 3 | 2(66.7) | 1(33.3) | ||
| Histological grade | |||||
| Ⅰ | 7 | 3(42.8) | 4(57.2) | 1.161 | 0.560 |
| Ⅱ | 538 | 263(48.8) | 275(51.2) | ||
| Ⅲ | 29 | 17(58.6) | 12(41.4) | ||
| Molecular classification | |||||
| Luminal A | 237 | 136(57.3) | 101(42.7) | 11.562 | 0.009 |
| Luminal B | 186 | 81(43.5) | 105(56.5) | ||
| HER2 enriched | 78 | 31(39.7) | 47(60.3) | ||
| Triple negative breast cancer | 73 | 35(47.9) | 38(52.1) | ||
| ER | |||||
| Positive | 422 | 215(50.9) | 207(49.1) | 1.725 | 0.189 |
| Negative | 152 | 68(44.7) | 84(55.3) | ||
| PR | |||||
| Positive | 362 | 187(51.6) | 175(48.4) | 2.174 | 0.140 |
| Negative | 212 | 96(45.2) | 116(54.8) | ||
| Ki-67 (%) | |||||
| <14 | 78 | 43(55.1) | 35(44.9) | 1.225 | 0.268 |
| ≥14 | 496 | 240(48.3) | 256(51.7) | ||
| HER2 | |||||
| Positive | 185 | 75(40.5) | 110(59.5) | 8.386 | 0.004 |
| Negative | 389 | 208(53.4) | 181(46.6) | ||
| P53 | |||||
| Positive | 170 | 77(45.2) | 93(54.8) | 1.553 | 0.213 |
| Negative | 404 | 206(50.9) | 198(49.1) |
Tab.3
Independent variable and dependent variable assignments"
| Variable | Assignment |
|---|---|
| Dependent variable | 0=LNB group; 1=HNB group |
| Independent variables | |
| Quadrant | 0=Upper outer; 1=Non upper outer |
| Distance from surface | 0=<5 mm; 1=≥5 mm |
| Lymph node longitudinal diameter | 0=<20 mm; 1=≥20 mm |
| Short diameter of lymphnode | 0=<8.6 mm; 1=≥8.6 mm |
| Lymph node aspect ratio | 0=<2; 1=≥2 |
| Lymphnode portal | 0=Clear; 1=Unclear |
| Molecular typing | 0=Luminal A; 1=Other |
| HER2 | 0=Positive; 1=Negative |
Tab.4
Logistic regression analysis of axillary lymphnodal metastasis burden in breast cancer"
| Factor | B | SE | Waldχ2 | OR | 95%CI | P | |
|---|---|---|---|---|---|---|---|
| Lower limit | Upper limit | ||||||
| Quadrant | -0.435 | 0.188 | 5.329 | 0.648 | 0.448 | 0.937 | 0.021 |
| Distance from the surface | -1.263 | 0.444 | 8.326 | 0.283 | 0.118 | 0.676 | 0.016 |
| Molecular typing | 0.447 | 0.222 | 4.068 | 1.564 | 1.013 | 2.415 | 0.044 |
| HER2 | -0.324 | 0.236 | 1.888 | 0.724 | 0.456 | 1.148 | 0.169 |
| Lymphnode longitudinal diameter | 0.718 | 0.192 | 14.053 | 2.050 | 1.409 | 2.984 | <0.01 |
| Short diameter of lymphnode | 0.888 | 0.185 | 23.124 | 2.430 | 1.692 | 3.490 | <0.01 |
| Lymphnode aspect ratio | 0.461 | 0.185 | 6.196 | 1.585 | 1.103 | 2.279 | 0.013 |
| Lymphnode portal | 0.783 | 0.184 | 16.181 | 2.092 | 1.460 | 2.998 | <0.01 |
| [1] | KIM H, LEE S B, NAM S J, et al. Survival of breast-conserving surgery plus radiotherapy versus total mastectomy in early breast cancer[J]. Ann Surg Oncol, 2021, 28(9): 5039-5047. |
| [2] | 李智博, 周军. 超声对乳腺癌腋窝淋巴结状态评估的应用进展[J]. 实用医学杂志, 2020, 36(22): 3161-3165. |
| [3] | GIULIANO A E, BALLMAN K V, MCCALL L, et al. Effect of axillary dissection vs No axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial[J]. JAMA, 2017, 318(10): 918-926. |
| [4] | 国家超声医学质量控制中心, 中华医学会超声医学分会. 乳腺疾病超声检查质量控制专家共识(2019版)[J]. 中华超声影像学杂志, 2020, 29(1): 1-5. |
| [5] | ADLER D D, CARSON P L, RUBIN J M, et al. Doppler ultrasound color flow imaging in the study of breast cancer: Preliminary findings[J]. Ultrasound Med Biol, 1990, 16(6): 553-559. |
| [6] | 中国抗癌协会乳腺癌专业委员会, 中华医学会肿瘤学分会乳腺肿瘤学组, 邵志敏. 中国抗癌协会乳腺癌诊治指南与规范(2024年版)[J]. 中国癌症杂志, 2023, 33(12): 1092-1186. |
| [7] | GOLDHIRSCH A, WOOD W C, COATES A S, et al. Strategies for subtypes: dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011[J]. Ann Oncol, 2011, 22(8): 1736-1747. |
| [8] | GRADISHAR W J, ANDERSON B O, ABRAHAM J, et al. Breast cancer, version 3.2020, NCCN clinical practice guidelines in oncology[J]. J Natl Compr Cancer Netw, 2020, 18(4): 452-478. |
| [9] | 时兆婷, 乐坚, 陈雅玲, 等. 浸润性乳腺癌超声征象与腋下淋巴结转移的相关性研究[J]. 中华超声影像学杂志, 2017, 26(5): 424-429. |
| [10] | 常乾坤, 白春强, 王伟芳, 等. 三阴性乳腺癌临床及超声表现与腋窝淋巴结转移的相关性分析[J]. 医学研究生学报,2022,35(12):1304-1308. |
| [11] | 陈晨. 高频彩色多普勒超声联合超声造影在乳腺癌腋下转移性淋巴结鉴别诊断中的应用[J]. 现代肿瘤医学, 2021, 29(3): 462-466. |
| [12] | 牛梓涵, 朱庆莉, 姜玉新. 超声在早期乳腺癌腋窝淋巴结转移诊断中的应用进展[J]. 中华超声影像学杂志, 2023, 32(10): 889-893. |
| [13] | 李卓璇, 童一苇, 陈小松, 等. 腋窝临床淋巴结阳性超声特征与乳腺癌淋巴结转移负荷及预后的相关性研究[J]. 中国癌症防治杂志, 2022, 14(4): 393-399. |
| [14] | GRADISHAR W J, ANDERSON B O, BALASSANIAN R, et al. NCCN guidelines insights: breast cancer, version 1.2017[J]. J Natl Compr Canc Netw, 2017, 15(4): 433-451. |
| [15] | 蔡林利, 宋宏萍, 巨艳, 等. 超声结合临床病理指标模型对T1-2期乳腺癌腋窝淋巴结转移的预测价值[J]. 中华医学超声杂志(电子版), 2024, 21(2): 143-150. |
| [16] | 桑田, 康燕飞, 曹玉文, 等. 乳腺癌肿块弹性特征及免疫组化指标预测腋窝淋巴结转移的价值[J]. 中国医学影像学杂志, 2022, 30(8): 776-782. |
| [17] | 桑田, 张海俊, 曹玉文, 等. Logistic回归分析乳腺癌常规超声征象与腋窝淋巴结转移的关系[J]. 中国医学影像技术, 2021, 37(8): 1158-1162. |
| [18] | DUAN Y, ZHU Y Y, NIE F, et al. Predictive value of combining clinicopathological, multimodal ultrasonic characteristics in axillary lymph nodal metastasis burden of patients with cT1-2N0 breast cancer[J]. Clin Hemorheol Microcirc, 2022, 81(3): 255-269. |
| [19] | 罗海愉, 朱丽璋, 张屿森, 等. 术前超声与临床T1-2期乳腺癌腋窝淋巴结负荷的相关性分析[J]. 中国超声医学杂志, 2021, 37(8): 859-861. |
| [20] | 石丽楠, 曹春莉, 桑田, 等. 基于乳腺癌超声特征及临床病理指标的列线图预测腋窝淋巴结转移风险[J]. 中国医学影像学杂志, 2024, 32(4): 332-338. |
| [21] | 桑田, 任学刚, 王烨, 等. 超声联合病理参数预测乳腺癌腋窝淋巴结转移的价值[J]. 中华超声影像学杂志, 2022, 31(8): 691-697. |
| [22] | MURATA T, WATASE C, SHIINO S, et al. Development and validation of a preoperative scoring system to distinguish between nonadvanced and advanced axillary lymph node metastasis in patients with early-stage breast cancer[J]. Clin Breast Cancer, 2021, 21(4): e302-e311. |
| [23] | 郝如意, 陈武, 刘晓芳, 等. 乳腺癌多模态超声边缘带征象与预后因素关系的研究[J]. 医学研究杂志, 2022, 51(12): 84-88. |
| [24] | 康佳, 吴桐, 张蕾, 等. 不同分子分型乳腺癌的多模态超声特征和临床病理对照研究[J]. 中华超声影像学杂志, 2020, 29(4): 330-336. |
| [1] | Lina ZHANG,Zhesi MENG,Long BA,Jun MENG. Research progress in relationship between cell division cycle protein 6 and occurrence and development of tumor [J]. Journal of Jilin University(Medicine Edition), 2026, 52(3): 847-853. |
| [2] | Mengmeng ZHAO,Yalu WANG,Yuxiang XU,Kaige YANG,Yuwen CAO,Wenhu ZHOU,Jing FEI,Wen WANG,Chenghua LUO,Jianming HU. Effects of hydrogen sulfide synthase CBS and CSE on malignant biological behaviour of breast cancer cells [J]. Journal of Jilin University(Medicine Edition), 2025, 51(1): 34-43. |
| [3] | Xiuyan YU,Ting LI,Zhanjie CONG,Wenlong WANG,Xiaowei ZHANG,Xuefeng WU. Combined detection of hMAM, SBEM and CEACAM19 mRNA in peripheral blood of breast cancer patients and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2022, 48(1): 195-202. |
| [4] | Xiuyan YU,Chunying TIAN,Xiaowei ZHANG,Xuefeng WU. Clinical significances of serum levels of SBEM, hMAM and CEACAM19 in early diagnosis of breast cancer [J]. Journal of Jilin University(Medicine Edition), 2021, 47(6): 1518-1525. |
| [5] | Yang YU,Sainan LIU,Yunkai LIU,Yong LI,Yichun QIAO,Yi CHENG. Bioinformatic analysis on expression characteristics of PRPS2 and its relationship with prognosis of breast cancer [J]. Journal of Jilin University(Medicine Edition), 2021, 47(5): 1229-1236. |
| [6] | Qing WANG,Siqi XIE,Kai ZHENG,Yiyin TANG,Hongwan LI,Hengyu ZHANG,Mingjian TAN,Lei PENG,Dequan LIU,Shicong TANG. Detection of serum vitamin-B levels in breast cancer patients receiving different chemotherapy regimens and its clinical significance [J]. Journal of Jilin University(Medicine Edition), 2021, 47(3): 724-730. |
| [7] | Haoxuan TANG,Nanfeng MENG,Meiling DU,Wei WANG,Tao HE. Inhibitory effect of new VEGF monoclonal antibody combined with all-trans retinoic acid on proliferation of breast cancer MCF-7 cells [J]. Journal of Jilin University(Medicine Edition), 2021, 47(2): 344-351. |
| [8] | KONG Wencong, HE Wubin, SU Rongjian, JIA Daqi, GU Yanjiao, WANG Yue, DU Xiaoyuan. Inhibitory effect and apoptosisinduction of MST1R inhibitor BMS-777607 on proliferation of breast cancer MCF-7 cells [J]. Journal of Jilin University(Medicine Edition), 2020, 46(03): 451-457. |
| [9] | CHEN Zhouhua, GONG Hui, FENG Lei, XIAO Yujie, HUANG Lizhong. Induction of LPS on epithelial mesenchymal transition in breast cancer MDA-MB-231 cells and its effect on β-catenin expression [J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 309-315. |
| [10] | ZHOU Chun, WANG Guanghua, ZHANG Bangzhu. Effects of miR-367 on proliferation, invasion and migration of human breast cancer MCF-7 cells and their mechanisms [J]. Journal of Jilin University(Medicine Edition), 2019, 45(06): 1353-1360. |
| [11] | YANG Zhuangqing, LU Mei, YANG Xiaojuan, WANG Chang'an, ZOU Jieya. Inhibitory effect of inhibiting TRIM24 gene expression on proliferation, apopotosis,invasion and migration of breast cancer MCF-7 cells [J]. Journal of Jilin University(Medicine Edition), 2019, 45(06): 1379-1383. |
| [12] | YUE Yuan, XU Yinglian, WANG Jingjing, SUN Minying, ZHANG Zenan, ZHAO Xinyue, LI Zongpu, TAI Guixiang. Inhibitory effects of down-regulation of JNK enzymatic activity on growth of human prostate cancer cells, hepatocellular carcinoma cells and breast cancer cells [J]. Journal of Jilin University(Medicine Edition), 2019, 45(05): 1046-1051. |
| [13] | YU Xiuyan, WAN Guangcai, SUN Hongshuai, ZHU Hua, GAO Haiyan, WU Xuefeng. Relationship between fibrinogen and prognosis of breast cancer patients:A Meta-analysis [J]. Journal of Jilin University(Medicine Edition), 2019, 45(05): 1092-1097. |
| [14] | TAN Qi, REN Liqun, ZHANG Yibing, WANG Yadi, GU Zehui, HUANG Peng, CHEN Suxian. Application of bioinformatics in screening of miRNA biomarkers in triple-negative breast cancer [J]. Journal of Jilin University(Medicine Edition), 2019, 45(05): 1098-1105. |
| [15] | WANG Shuang, KANG Lihua, GUAN Meng, WANG Lei, LI Beibei, ZHAO Yue, SONG Yanqiu, YANG Tingting. Clinical application of apatinib mesylate combined with chemotherapy in treatment of patients with advanced breast cancer [J]. Journal of Jilin University(Medicine Edition), 2019, 45(05): 1152-1158. |